Preclinical Atherosclerosis is Worth Going After

Sunday, March 9, 2025

8:40 AM – 8:48 AM ET

Speaker(s)

Renu Virmani, MD

President
CVPath Institute, Inc.
Gaithersburg, Maryland, United States

Disclosure(s): Amplitude Vascular Systems: Grant/Research Support (Ongoing); BD: Grant/Research Support (Ongoing); celenova: Grant/Research Support (Ongoing); Concept Medical: Grant/Research Support (Ongoing); Edward Lifesciences: Grant/Research Support (Ongoing); Imperative Care: Grant/Research Support (Ongoing); Recor Medical, Inc.: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); the jacobs institute: Grant/Research Support (Ongoing); Vascudyne: Grant/Research Support (Ongoing); Xeltis: Grant/Research Support (Ongoing)

Disclosure(s):

Renu Virmani, MD: Amplitude Vascular Systems: Grant/Research Support (Ongoing); BD: Grant/Research Support (Ongoing); celenova: Grant/Research Support (Ongoing); Concept Medical: Grant/Research Support (Ongoing); Edward Lifesciences: Grant/Research Support (Ongoing); Imperative Care: Grant/Research Support (Ongoing); Recor Medical, Inc.: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); the jacobs institute: Grant/Research Support (Ongoing); Vascudyne: Grant/Research Support (Ongoing); Xeltis: Grant/Research Support (Ongoing)